Healthcare
QSAM Biosciences
View On Demand
QSAM CEO, Douglas Baum and Justin Walsh PhD, analyst for Jones Trading discuss de-risketreatment for bone cancer
Menu
QSAM CEO, Douglas Baum and Justin Walsh PhD, analyst for Jones Trading discuss de-risketreatment for bone cancer
Gain Therapeutics is deploying its SEE-Tx™ platform to develop a treatment for Parkinson’s disease by guiding misfolded proteins back into their proper shape
Silence Therapeutics’ mRNAi Gold Platform transforms peoples’ lives by silencing diseases through precision engineered medicines.
New strategy helps Sonim Technologies [NASDAQ: SONM] increase sales 95% and achieve positive GAAP net income in Q1 2023
Join this closing bell event with the CEO of CareCloud (NASDAQ: CCLD) and a leading analyst for an exploration of AI’s impact on healthcare.
One of the most efficient and productive ways to mine precious metals is from the 53 megatons of e-Waste produced globally every year
Kineta has developed a new monoclonal antibody designed to reverse immunosuppression and stimulate T Cells.
A clinical-stage biotech company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases
A HealthTech company that provides doctors, clinics, and health systems the tools and support they need to run all aspects of their business
BloombergNEF projects more than 1 million battery-electric light and medium-duty commercial vehicles will be on the road in the U.S. by 2030.
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2021 FORCE Family Office